Recent Posts
Featured Posts

Novartis trial win lifts profile of new breast cancer drug

Novartis’s efforts to tackle an elusive gene mutation behind tough-to-treat breast cancer were rewarded on Thursday, as the Swiss drugmaker said one of its investigational medicines slowed disease progression.

nalysts said the drug, called BYL719, is on a trajectory to take a leading role in advanced breast cancer treatment.

Novartis said its drug combined with hormone therapy improved progression-free survival in breast cancer patients whose tumors had hormone receptors but not so-called HER2 proteins.

To read the full article, click HERE

REUTERS/Arnd Wiegmann/File Photo

Search By Tags
Archive
  • Facebook - White Circle
  • Twitter - White Circle
  • Instagram - White Circle
  • LinkedIn - White Circle

Connect with us on social media

© 2020 Care For A Cure, Inc. is a non-profit organization

with a 501(c)(3) tax exempt status. All rights reserved.